Oxoglutarate dehydrogenase complex
An enzyme complex involved in the citric acid cycle
Overview
The oxoglutarate dehydrogenase complex (OGDC) is a multi-enzyme complex that plays a crucial role in the citric acid cycle, also known as the Krebs cycle or TCA cycle. This complex is responsible for the conversion of alpha-ketoglutarate (also known as 2-oxoglutarate) into succinyl-CoA and carbon dioxide. This reaction is a key step in the metabolic pathway that generates energy through the oxidation of acetyl-CoA derived from carbohydrates, fats, and proteins.
Structure
The oxoglutarate dehydrogenase complex is composed of multiple copies of three core enzymes:
- E1: Oxoglutarate dehydrogenase (also known as 2-oxoglutarate dehydrogenase) - This enzyme catalyzes the decarboxylation of alpha-ketoglutarate.
- E2: Dihydrolipoyl transsuccinylase - This enzyme facilitates the transfer of the succinyl group to coenzyme A, forming succinyl-CoA.
- E3: Dihydrolipoyl dehydrogenase - This enzyme regenerates the oxidized form of lipoamide, a cofactor required for the activity of E2.
The complex also requires several cofactors, including thiamine pyrophosphate (TPP), lipoic acid, coenzyme A, FAD, and NAD+.
Function
The primary function of the oxoglutarate dehydrogenase complex is to catalyze the conversion of alpha-ketoglutarate to succinyl-CoA, a reaction that involves the decarboxylation of alpha-ketoglutarate and the reduction of NAD+ to NADH. This reaction is crucial for the continuation of the citric acid cycle, which is essential for cellular respiration and energy production.
Regulation
The activity of the oxoglutarate dehydrogenase complex is tightly regulated by several mechanisms:
- Product inhibition: The complex is inhibited by its products, succinyl-CoA and NADH.
- Feedback inhibition: High levels of ATP and GTP inhibit the complex, while ADP and AMP activate it.
- Cofactor availability: The availability of cofactors such as TPP, lipoic acid, and NAD+ can affect the activity of the complex.
Clinical Significance
Deficiencies or malfunctions in the oxoglutarate dehydrogenase complex can lead to metabolic disorders. For example, a deficiency in this complex can result in a buildup of alpha-ketoglutarate and a decrease in energy production, which can contribute to conditions such as lactic acidosis and neurological disorders.
Related pages
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian